Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related kaposi sarcoma

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 3, 2012, Pages 301-304

  Rosado, Flavia G Nunes ^a   Itani, Doha M ^a   Coffin, Cheryl M ^a   Cates, Justin M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; FLI1 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; TRANSCRIPTION FACTOR FLI 1; TUMOR MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; METABOLISM; METHODOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAINING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD31; ANTIGENS, CD34; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROTO-ONCOGENE PROTEIN C-FLI-1; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 84858017709     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0213-OA     Document Type: Article

References (22)

1. Chang Y, Cesarman E, Pessin MS, Lee F, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266(5192):1865-1869.
2. Braun M. Classics in oncology: idiopathic multiple pigmented sarcoma of the skin by Kaposi. CA Cancer J Clin. 1982;32(6):340-347.
3. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000;342(14):1027- 1038. (Pubitemid 30180651)
4. Beral V Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990;335(8682): 123-128. (Pubitemid 20032724)
5. Calonje E, Fletcher CDM. Vascular tumors. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumors. 3rd ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2007:41-82.
6. Parfitt JR, Rodriguez-Justo M, Feakins R, Novelli MR. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour. Histopathology. 2008;52(7):816-823. (Pubitemid 351724907)
7. Pantanowitz L, Schwartz EJ, Dezube BJ, Kohler S, Dorfman RF, Tahan SR. C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma. Appl Immunohistochem Mol Morphol. 2005;13(2):162-166. (Pubitemid 40726853)
8. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens\-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7(1):82-90.
9. Nickoloff BJ. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. Arch Dermatol. 1993;129(2):250-251. (Pubitemid 23063890)
10. Russell Jones R, Orchard G, Zelger B, Wilson Jones E. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol. 1995;48(11):1011-1016.
11. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15(4):434-440. (Pubitemid 34326952)
12. Dubina M, Goldenberg G. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40. J Am Acad Dermatol. 2009;61(2):276-280.
13. Kalof AN, Cooper K. D2-40 immunohistochemistry\-so far! Adv Anat Pathol. 2009;16(1):62-64.
14. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005;46(4):396-402. (Pubitemid 40516755)
15. Debelenko LV, Perez-Atayde AR, Mulliken JB, Liang MG, Archibald TH, Kozakewich HP. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol. 2005;18(11):1454-1460. (Pubitemid 41509400)
16. Ishida M, Kushima R, Okabe H. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin. J Cutan Pathol. 2008;35(10): 926-930.
17. Gomaa AH, Yaar M, Bhawan J. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics. Am J Dermatopathol. 2007;29(1):18-21. (Pubitemid 46220234)
18. Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25(8):1061-1066. (Pubitemid 32685904)
19. Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohisto-chemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroec-todermal tumor. Am J Surg Pathol 2000;24(12):1657-1662.
20. Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17(5):547-552. (Pubitemid 38868421)
21. Hong A, Davies S, Lee CS. Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen-1 in Kaposi's sarcoma. Pathology. 2003;35(5):448-450. (Pubitemid 37310988)
22. Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004;121(3): 335-342. (Pubitemid 38298166)